Cargando…
Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups
Polyomaviruses infect many species, including humans. So far, 15 polyomaviruses have been described in humans, but it remains to be established whether all of these are genuine human polyomaviruses. The most recent polyomavirus to be detected in a person is Quebec polyomavirus (QPyV), which was iden...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158138/ https://www.ncbi.nlm.nih.gov/pubmed/34070030 http://dx.doi.org/10.3390/microorganisms9051082 |
_version_ | 1783699821263060992 |
---|---|
author | Prezioso, Carla Van Ghelue, Marijke Pietropaolo, Valeria Moens, Ugo |
author_facet | Prezioso, Carla Van Ghelue, Marijke Pietropaolo, Valeria Moens, Ugo |
author_sort | Prezioso, Carla |
collection | PubMed |
description | Polyomaviruses infect many species, including humans. So far, 15 polyomaviruses have been described in humans, but it remains to be established whether all of these are genuine human polyomaviruses. The most recent polyomavirus to be detected in a person is Quebec polyomavirus (QPyV), which was identified in a metagenomic analysis of a stool sample from an 85-year-old hospitalized man. We used PCR to investigate the presence of QPyV DNA in urine samples from systemic lupus erythematosus (SLE) patients (67 patients; 135 samples), multiple sclerosis patients (n = 35), HIV-positive patients (n = 66) and pregnant women (n = 65). Moreover, cerebrospinal fluid from patients with suspected neurological diseases (n = 63), nasopharyngeal aspirates from patients (n = 80) with respiratory symptoms and plasma samples from HIV-positive patients (n = 65) were examined. QPyV DNA was found in urine from 11 (16.4%), 10 (15.4%) and 5 (14.3%) SLE patients, pregnant women, and multiple sclerosis patients, respectively. No QPyV DNA could be detected in the other samples. Alignment with the only available QPyV sequence in the GenBank revealed amino acid substitutions in the HI-loop of capsid protein VP1 in 6/28 of the isolates. Our results show that QPyV viruria can occur, but whether it may cause clinical symptoms in the patients remains to be determined. |
format | Online Article Text |
id | pubmed-8158138 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81581382021-05-28 Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups Prezioso, Carla Van Ghelue, Marijke Pietropaolo, Valeria Moens, Ugo Microorganisms Communication Polyomaviruses infect many species, including humans. So far, 15 polyomaviruses have been described in humans, but it remains to be established whether all of these are genuine human polyomaviruses. The most recent polyomavirus to be detected in a person is Quebec polyomavirus (QPyV), which was identified in a metagenomic analysis of a stool sample from an 85-year-old hospitalized man. We used PCR to investigate the presence of QPyV DNA in urine samples from systemic lupus erythematosus (SLE) patients (67 patients; 135 samples), multiple sclerosis patients (n = 35), HIV-positive patients (n = 66) and pregnant women (n = 65). Moreover, cerebrospinal fluid from patients with suspected neurological diseases (n = 63), nasopharyngeal aspirates from patients (n = 80) with respiratory symptoms and plasma samples from HIV-positive patients (n = 65) were examined. QPyV DNA was found in urine from 11 (16.4%), 10 (15.4%) and 5 (14.3%) SLE patients, pregnant women, and multiple sclerosis patients, respectively. No QPyV DNA could be detected in the other samples. Alignment with the only available QPyV sequence in the GenBank revealed amino acid substitutions in the HI-loop of capsid protein VP1 in 6/28 of the isolates. Our results show that QPyV viruria can occur, but whether it may cause clinical symptoms in the patients remains to be determined. MDPI 2021-05-18 /pmc/articles/PMC8158138/ /pubmed/34070030 http://dx.doi.org/10.3390/microorganisms9051082 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Prezioso, Carla Van Ghelue, Marijke Pietropaolo, Valeria Moens, Ugo Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups |
title | Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups |
title_full | Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups |
title_fullStr | Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups |
title_full_unstemmed | Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups |
title_short | Detection of Quebec Polyomavirus DNA in Samples from Different Patient Groups |
title_sort | detection of quebec polyomavirus dna in samples from different patient groups |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158138/ https://www.ncbi.nlm.nih.gov/pubmed/34070030 http://dx.doi.org/10.3390/microorganisms9051082 |
work_keys_str_mv | AT preziosocarla detectionofquebecpolyomavirusdnainsamplesfromdifferentpatientgroups AT vangheluemarijke detectionofquebecpolyomavirusdnainsamplesfromdifferentpatientgroups AT pietropaolovaleria detectionofquebecpolyomavirusdnainsamplesfromdifferentpatientgroups AT moensugo detectionofquebecpolyomavirusdnainsamplesfromdifferentpatientgroups |